Name: Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein (Video) | JoVE Journal
Uploaded: 2013-01-28T13:00:00.000+00:00
Duration: 14 min 32 s
Description: Learn to produce high-quality plasma retinol binding protein for real-time analysis of STRA6 receptor activities. This protocol enables monitoring of retinol transport mechanisms using bacterial expression and HPLC purification.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

Supported by National Institutes of Health grant R01EY018144.

1. Production, Refolding, and HPLC Purification of Holo-RBP
<ol>
	<li>Transform BL-21cells with the pET3a vector harboring the cDNA for human RBP with 6x His tag on the N-terminus. Grow the transformed BL-21 cells in a shaker at 37 &deg;C in 40 ml LB media with carbenicillin until O.D. at 600 nm reaches 0.5. Induce RBP protein expression by adding IPTG to 1mM. Grow the bacteria at 37 &deg;C another 5 hr.</li>
	<li>RBP produced in E.coli is mostly present in insoluble inclusion bodies. To enrich inclusion bodies, pellet cells at 10,000 x g for 20 min. Then sonicate the cells on ice in 5 ml PBS with protease inhibitors, followed by 2 cycles of freezing and thawing. Pellet down the inclusion bodies at 20,000 x g for 30 min at 4 &deg;C. Remove supernatant and keep the pellet on ice.</li>
	<li>Solubilize the inclusion body pellet by sonication in 10 ml 7.5 M guanidine hydrochloride. Add a half volume (5 ml) of 25 mM Tris buffer, pH 9.0 and DTT to a final concentration of 10 mM. Vigorously mix solution on a vortex mixer overnight at room temperature to fully reduce and denature proteins.</li>
	<li>Centrifuge the protein solution to remove insoluble material at 18,000 x g for 20 min at 4 &deg;C. After the spin, transfer the supernatant to a new tube and place the tube on ice.</li>
	<li>Prepare four volumes (60 ml) of refolding buffer (25 mM Tris, pH 9.0, 0.3 mM cystine, 3.0 mM cysteine, 1 mM EDTA). Degas the refolding buffer. Also prepare 600 &mu;l 10 mM retinol in ethanol under dim red light. Keep it in the dark on ice. Both the refolding buffer and retinol solution need to be freshly prepared.</li>
	<li>Cool both the protein solution and the refolding buffer on ice for at least 30 min. Higher temperature likely reduces the quality of refolded RBP. Add 1 ml refolding buffer dropwise and 10 &mu;l retinol solution in turn while protein solution is vigorously mixed in a beaker on ice. Repeat this step until all refolding buffer and retinol are added. Keep stirring the reaction on ice in the dark for 5 hr.</li>
	<li>Spin down the refolding reaction at 24,000 x g for 30 min at 4 &deg;C. It is essential to remove the aggregates right after the refolding reaction.</li>
	<li>Concentrate the supernatant solution using Amicon Ultra 15 concentrator (MWCO 10 K) to about 10 ml. Do not concentrate the refolded solution more than this level. Concentrating too much will lead to protein aggregation and lowers the final yield and quality of correctly folded RBP. Dilute the concentrated sample with cold PBS to 100 ml. The purpose of this step is to remove the components in the refolding reaction that interfere with nickel purification.</li>
	<li>Spin the solution one more time at 24,000 x g for 20 min at 4 &deg;C. It is important to remove any precipitate. Transfer the supernatant to two 50 ml tubes, each containing 1 ml Ni-NTA slurry that has been washed with PBS. Rotate the tubes at 4 &deg;C for one hour. Incubating diluted solution for 1 hr can cause the precipitation of misfolded proteins which need to be removed.</li>
	<li>Spin down the tubes at 500 x g for 3 min. Remove supernatant carefully. Anything floating should be removed. Add cold PBS to 30 ml for each tube. Spin again and remove the supernatant. Repeat this process until you see nothing but beads in the tube.</li>
	<li>Transfer the Ni-NTA resin to an empty column. Wash resin with 20 column volumes of 10 mM imidazole, 500 mM NaCl in PBS. Elute His-RBP in 5 column volumes of 100 mM imidazole in PBS. Do not store this solution for an extended period of time, and freezing reduces the final yield and quality. For the best result, purify RBP by HPLC immediately.</li>
	<li>Dialyze His-RBP purified from the Ni-NTA resin against 25 mM Tris, pH 8.4, and 120 mM NaCl. A concentrator can also be used for buffer exchange. Clear samples for HPLC by centrifugation at 16,000 x g for 10 min at 4 &deg;C right before each run.</li>
	<li>Purify holo-RBP on HPLC using an ion exchange column AX-300 by a NaCl step gradient (220 mM 12 min, 360 mM 15 min, and 1,000 mM 15 min) using 25 mM Tris, pH 8.4 as mobile phase at 1 ml/min. As NaCl concentration rises, holo-His-RBP is released while apo-RBP and misfolded RBP stay bound to the column (Figure 1). If RBP refolding is not done optimally, misfolded RBP (e.g. misfolded RBP-I in Figure 1) can predominate the whole preparation.</li>
	<li>Recover the correctly folded holo-RBP from the peak fractions at 360 mM NaCl. Carefully monitor the elution profile of correctly folded and misfolded His-RBP. At 1,000 mM NaCl, most of misfolded His-RBP should be released.</li>
	<li>Fractions containing holo-RBP are pooled, concentrated, and dialyzed against PBS overnight at 4 &deg;C. Check the final yield and quality (330 nm/280 nm) by spectrophotometer. Correctly folded product should have a 330 nm/280 nm ratio of slightly higher than 1 (Figure 1).</li>
	<li>To produce apo-RBP, add an equal volume of heptane to the purified holo-RBP and mix gently by rotating overnight at 4 &deg;C. Centrifuge at 16,000 g for 10 min at 4 &deg;C and carefully transfer the bottom aqueous phase to a new tube (avoiding the precipitate at the interface). Repeat the process three times with a 3 hr incubation for each. Check absorption on a Nanodrop spectrophotometer to make sure the 330 nm peak has decreased to the background level.</li>
</ol>
2. Real-time Monitoring of STRA6-catalyzed Retinol Release and Retinol Loading
<ol>
	<li>Block a black 96-well Microfluor-2 plate (Thermo Scientific) with 200 &mu;l of Blocker Casein (Pierce) overnight at 4 &deg;C to prevent nonspecific sticking of holo-RBP to the plastic. Blocker Casein gives the best blocking effect of the all the blocking solutions we tested.</li>
	<li>Membranes freshly prepared from cells expressing STRA6 or control cells are washed using PBS and passed through a Hamilton syringe (Gastight #1710) 6 times to produce a uniform suspension in PBS. We typically use membranes derived from 1/100 to 1/20 of cells grown on a 100 mm dish per reaction.</li>
	<li>Wash the coated wells of the Microfluor-2 plate once with 200 &mu;l of PBS. Cool the plate on ice before addition of membrane suspension (50 &mu;l per well).</li>
	<li>Real time monitoring of retinol fluorescence is measured using fluorescence optics of the POLARstar Omega (BMG Labtech) with the excitation filter 320ex and the emission filter 460-10. The program is set to the Endpoint reading mode. The Plate Mode can also be used to measure a time course if the time intervals are not varied. The signal from each time point is the average of 10 measurements (orbital averaging with a diameter of 2 mm) and the gain is set at 1,800. The plate is shaken for 10 sec at 500 rpm using double-orbital shaking before each measurement.</li>
	<li>To start the retinol release assay, the wells are read once using the Endpoint reading mode before holo-RBP (typically 1 &mu;M final concentration) is added at 0 min. As soon as holo-RBP is added, the reaction is monitored continuously every 5-10 min for 1-3 hr. To start the retinol loading assay, all-trans retinol (typically 1 &mu;M final concentration) is added to the wells under dim red light. The plate is read once before apo-RBP is added at 0 min. As soon as apo-RBP is added, the reaction is monitored continuously every 5-10 min for 1-3 hr.</li>
	<li>After all measurements are done, download the raw data (example shown in Figure 2) from the Omega Data Analysis software (BMG Labtech) to Microsoft Excel for data analysis. Each time point generates a file that contains the readings of all experimental conditions. For example, if there are 20 time points, consolidate 20 files into one Excel file for data analysis.</li>
	<li>For data analysis, the fluorescence signals before the addition of retinol or holo-RBP at 0 min are considered background signals and subtracted from the final fluorescence signals at all time points. Although the background signals are low compared to retinol fluorescence in holo-RBP, subtracting the background eliminates the nonspecific influence of light scattering by the membranes and makes it possible to focus on the retinol fluorescence of holo-RBP or retinol added at 0 min.</li>
</ol>
3. Real-time Monitoring of STRA6-catalyzed Transport of Retinol From Holo-RBP to CRBP-I
<ol>
	<li>Retinol-EGFP is a new fluorescence resonance transfer (FRET) pair that has recently been established 41. STRA6-catalyzed retinol transport from holo-RBP to EGFP-CRBP-I is monitored in real time by measuring retinol-EGFP FRET. EGFP-CRBP-I fusion protein with 6XHis tag (EGFP-CRBP-I) is produced in mammalian cells and is purified on Ni-NTA resin before the experiment. EGFP-CRBP-I can be stored in PBS with protease inhibitors for a short period of time at 4 &deg;C. Alternatively the fusion protein is frozen in -80 &deg;C in small aliquots.</li>
	<li>Before the reactions, prepare a blocked Microfluor-2 plate and membranes as described above. Wash the coated wells of the Microfluor-2 plate once with 200 &mu;l PBS before addition of membrane suspension (50 &mu;l per well).</li>
	<li>Real-time retinol-EGFP FRET is measured using POLARstar Omega with the excitation filter 320ex and the emission filters 460-10 and 510-10 using simultaneous duel emission fluorescence optics. The program is set to the Endpoint reading mode. The Plate Mode can also be used to measure a time course if the time intervals are not varied. The signal from each time point is the average of 10 measurements (orbital averaging with a diameter of 2 mm) and the gain is set at 1,800 per channel. The plate is shaken for 10 sec at 500 rpm using double-orbital shaking before each measurement.</li>
	<li>To start the reactions, EGFP-CRBP-I (typically 1 &mu;M final concentration) is added to the wells. The plate is read once using the Endpoint reading mode before holo-RBP is added at 0 min. As soon as holo-RBP is added, the reaction is monitored continuously by measurement every 5-10 min for 1-2 hr.</li>
	<li>After all measurements are done, download the raw data (example shown in Figure 3) from the Omega Data Analysis software to Microsoft Excel for data analysis as described above.</li>
	<li>Retinol-EGFP FRET is calculated by the dynamic change in the ratio of the acceptor/donor emission peaks47. The equation41 to calculate this ratio is [(510t-510b)/(460t-460b)], where 510t, 510b, 460t, and 460b represent emissions at 510 nm after initiation of the reaction (t=time point), at 510 nm before retinol or holo-RBP is added (b=background), at 460 nm after initiation of the reaction (t=time point), and at 460 nm before retinol or holo-RBP is added (b=background), respectively.</li>
</ol>

No conflicts of interest declared.

We share here an optimized RBP production protocol because RBP production and purification procedures are critical to generating correctly folded RBP. Given the possibility of misfolded RBP species and the presence of trace amounts of bacterial proteins even in HPLC purified bacteria-produced RBP, it is helpful to use native RBP from serum to confirm a conclusion related to RBP. Urine RBP, which is commercially available, is a complex mixture of many species of RBP including apo-RBP and holo-RBP 48,49.
<p...

Vitamin A is an organic molecule that is essential for human survival and the proper functioning of almost all human organs. Vitamin A derivatives (retinoids) participate in diverse biochemical and cellular events including the sensing of light for vision 1,2 and the regulation of gene expression and protein translation during embryonic development and in adult tissues 3-6. Although retinol has the ability to diffuse systemically, evolution came up with plasma retinol binding protein, a specific carrier protein for vitamin A transport in the blood to achieve high efficiency and specificity and to avoid toxicity associated with random diffusion 7-10. A high-affinity receptor that binds to RBP and takes up vitamin A was hypothesized in the 1970s 11-13. Despite evidence accumulated in three decades on the existence of the RBP receptor 14-31, the receptor hypothesis was debated for many years due to the existence of an incorrect definition of holo-RBP. The correct definition of holo-RBP is that it is the high affinity 1:1 complex between retinol and RBP. Repeated extraction of holo-RBP by organic solvent is necessary to produce apo-RBP. This definition is used by almost all labs studying RBP 7,9,32-35 or the RBP receptor 14-31,36-42. The incorrect definition of holo-RBP that was used to disprove the existence of the RBP receptor is the acute mixture of free retinol with apo-RBP. Since the function of the RBP receptor in vitamin A uptake from holo-RBP is to release retinol from holo-RBP, the RBP receptor would play no role in retinol uptake if retinol is free to begin with (as proposed by the incorrect definition of holo-RBP).
The recent identification of RBP receptor as a multitransmembrane domain protein called STRA636 and its function in vitamin A uptake from holo-RBP 36-43 strongly argues against the hypothesis that RBP does not need a receptor to deliver vitamin A. Detailed analyses revealed that STRA6 has 9 transmembrane domains with the N-terminus located extracellularly and C-terminus located intracellularly 40. Located between transmembrane 6 and 7 is an essential RBP binding domain 39. STRA6 is coupled to both LRAT and CRBP-I in vitamin A uptake from holo-RBP, but neither LRAT nor CRBP-I is absolutely required for enhanced STRA6 activity 41. STRA6's ability to catalyze retinol release from holo-RBP is the key to its vitamin A uptake activity 41. By relying on STRA6 to release its retinol, vitamin A delivery by RBP can transport vitamin A to target cells in peripheral tissues with high specificity and efficiency.
The critical importance of holo-RBP definition and preparation is illustrated not only by the historical debate on the existence of the RBP receptor, but also by three related recent papers based on holo-RBP definitions different from the original and correct definition 44-46. The first paper used the holo-RBP definition that was used to disapprove the existence of the RBP receptor to study the RBP receptor 44. The second and third papers came up with a third definition of holo-RBP that made it even less likely for retinol to be studied to form a proper complex with RBP 45,46. These studies prepared 3H-retinol/RBP by mixing holo-RBP (not even apo-RBP) with 3H-retinol. Since this assay did not have 3H-retinol/RBP formed and did not remove excessive free 3H-retinol 45,46, it is not an assay for 3H-retinol uptake from 3H-retinol/RBP, but is a free 3H-retinol diffusion assay. It has been shown previously that STRA6 does not enhance cellular uptake of free retinol by LRAT 38 or CRBP-I 41. Virtually all retinol is bound to RBP in the blood and there is no detectable free retinol. A main function of the RBP receptor is to catalyze retinol release from holo-RBP during retinol uptake from holo-RBP 41. If the retinol is artificially released or is in the free form to begin with 45,46, the RBP receptor is not needed. The dramatically different results obtained from the free retinol diffusion assay as compared to assays based on correctly prepared holo-RBP illustrate that correct preparation of RBP is crucial for its functional assays.
RBP can be purified from human serum 41, but the procedure is complex and the yield is low. An alternative approach is to produce RBP in E. coli. Because E. coli does not have the ability to correctly fold mammalian secreted proteins with more than one pair of disulfide bonds like RBP, it is essential to refold RBP and purify the correctly folded protein. Misfolded proteins not only behave differently from corrected folded RBP in various assays, but also cause protein aggregation during storage. For the same reason, apo-RBP is only produced from high-quality holo-RBP. We describe here an optimized protocol to produce high quality RBP 100% loaded with retinol through bacterial expression, refolding, and HPLC purification. HPLC purification not only removes incorrectly folded RBP but also significant bacterial contamination that can cause serious artifacts if RBP is used in signal transduction assays. We also describe two sensitive real-time monitoring techniques to study retinol transport by STRA6. Both techniques depend on high quality RBP. Due to space limitations, the classic techniques of radioactive retinoid-based and HPLC-based vitamin A uptake assays are not described here.

<table><tbody><tr><td>guanidine hydrochloride</td><td>EMD</td><td>5010</td><td></td></tr><tr><td>cystine</td><td>Sigma</td><td>C8755</td><td></td></tr><tr><td>cysteine</td><td>Sigma</td><td>C7352</td><td></td></tr><tr><td>EDTA</td><td>Fisher</td><td>BP118-500</td><td></td></tr><tr><td>Tris</td><td>Fisher</td><td>7786-1</td><td></td></tr><tr><td>DTT</td><td>EMD</td><td>3860</td><td></td></tr><tr><td>retinol</td><td>Sigma</td><td>R7632</td><td></td></tr><tr><td>carbenicillin</td><td>Fisher</td><td>BP2648-5</td><td></td></tr><tr><td>IPTG</td><td>EMD</td><td>5810</td><td></td></tr><tr><td>PBS</td><td>EMD</td><td>6508</td><td></td></tr><tr><td>NaCl</td><td>Fisher</td><td>BP358-10</td><td></td></tr><tr><td>Ni-NTA</td><td>Qiagen</td><td>1018244</td><td></td></tr><tr><td>imidazole</td><td>EMD</td><td>5720</td><td></td></tr><tr><td>heptane</td><td>EMD</td><td>HX0295-1</td><td></td></tr><tr><td>Blocker Casein</td><td>Pierce</td><td>37528</td><td></td></tr><tr><td>Amicon Ultra 15 concentrator (MWCO 10 K)</td><td>Millipore</td><td>UFC901024</td><td></td></tr><tr><td>Microfluor-2 plate </td><td>Fisher</td><td>14-245-177</td><td></td></tr><tr><td>Hamilton syringe Gastight #1710</td><td>Fisher</td><td>14-824-655</td><td></td></tr></tbody></table>

real-time analyses of retinol transport by the membrane receptor of plasma retinol binding protein

Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein

Vitamin A is essential for vision and the growth/differentiation of almost all human organs. Plasma retinol binding protein (RBP) is the principle and specific carrier of vitamin A in the blood. Here we describe an optimized technique to produce and purify holo-RBP and two real-time monitoring techniques to study the transport of vitamin A by the high-affinity RBP receptor STRA6. The first technique makes it possible to produce a large quantity of high quality holo-RBP (100%-loaded with retinol) for vitamin A transport assays. High quality RBP is essential for functional assays because misfolded RBP releases vitamin A readily and bacterial contamination in RBP preparation can cause artifacts. Real-time monitoring techniques like electrophysiology have made critical contributions to the studies of membrane transport. The RBP receptor-mediated retinol transport has not been analyzed in real time until recently. The second technique described here is the real-time analysis of STRA6-catalyzed retinol release or loading. The third technique is real-time analysis of STRA6-catalyzed retinol transport from holo-RBP to cellular retinol binding protein I (CRBP-I). These techniques provide high sensitivity and resolution in revealing RBP receptor's vitamin A uptake mechanism.

We present here representative results for holo-RBP production and purification by HPLC (Figure 1), real-time analysis of STRA6-catalyzed retinol release from holo-RBP and retinol loading into apo-RBP (Figure 2) and real-time analysis of STRA6-catalyzed retinol transport from holo-RBP to EGFP-CRBP-I (Figure 3).
Without refolding, RBP produced in bacteria is almost completely misfolded due to the presence of many incorrect disulfide bonds. Ther...

Here we describe an optimized technique to produce high-quality vitamin A/RBP complex and two real-time monitoring techniques to study vitamin A transport by STRA6, the RBP receptor.

Vitamin A is essential for vision and the growth/differentiation of almost all human organs.  Plasma retinol binding protein (RBP) is the principle and ...

This protocol shows the production of high quality plasma retinol binding protein that is used to study the activities of retinol binding protein receptor in real time. This is achieved by first expressing and purifying a large quantity of retinol binding protein from bacteria. The purified retinol binding protein is completely denatured and slowly refolded in the presence of its ligand retinol.Then the correctly refolded retinol binding protein is purified using HPLC to remove incorrectly folded protein and bacterial contaminants. Once high quality retinol binding protein is obtained, it can be used to study the activities of its membrane receptor in catalyzing retinol release, retinol loading, or retinol transport to cellular retinol binding protein one. In real time.Today I will demonstrate our improved protocol to reform and purify retinal binding protein producing bacteria. This technique can produce high quality retinal binding protein, which is essential for functional assays. I will demonstrate the newly developed techniques to study the receptor for retinal binding protein.The main advantage of these techniques over existing methods like radioactivity based or HPRC based techniques is that it allows you to monitor the progress of multiple reactions in real time. The most difficult part of this procedure is RVP withholding, which can both determine quality and yield of RVP. If the protein is not produced correctly, the resulting RVP preparation cannot be used for functional acids.Here we introduce some improvement that we developed over the years that will ensure success. Begin this protocol with the insoluble inclusion bodies from a 40 milliliter culture of BL 21 e coli in which human RBP protein with a six x his tag add 10 milliliters of 7.5 molar guine hydrochloride to the inclusion bodies and sonicate. Then add five milliliters of 25 millimolar triss pH nine and 75 microliters of 10 millimolar DTT, and rotate overnight.The next day centrifuge at 18 G for 20 minutes at four degrees Celsius to remove the insoluble proteins. After the spin, transfer the supernatant to a new tube and place the tube on ice. Then prepare the refolding buffer on ice as described in the accompanying text.Next, turn out the room lights to work under a dim red light while vigorously mixing the protein solution in a beaker on ice. Alternately, add 10 microliters of retinol solution for every one milliliter of refolding buffer for a total of 600 microliters of retinol solution and 60 milliliters of refolding buffer. Then continue stirring for five hours in the dark after another centrifugation.Concentrate the supernatant to about 10 milliliters using Anacon Ultra 15. After concentrating, dilute the sample to 100 milliliters. Using cold PBS.It is important to remove any precipitate at this point. Then purify the refolded RBP on nickel NTA resin elute in 100 millimolar ole in PBS. Concentrate the EIT using a concentrator with 10 kilodalton molecular weight cutoff to the volume one fifth to one 10th of the original volume.Then dilute by five to 10 times with tris plus sodium chloride and repeat the concentrating step after concentrating the protein. Transfer it to a 1.5 millimeter micro centrifuge tube immediately before the HPLC run to clear the samples centrifuge at 16, 000 G for 10 minutes at four degrees Celsius. Next, purify hollow RBP on HPLC using an ion exchange column by a sodium chloride step gradient of 220 millimolar for 12 minutes.360 millimolar for 15 minutes and 1000 millimolar for 15 minutes. Using 25 millimolar triss pH 8.0 as a mobile phase at one milliliter per minute. As the sodium chloride concentration rises, hollow hiss RBP is released.While APO RBP and misfolded RBP stay bound to the column. If RBP Refolding is not done optimally, misfolded RBP can dominate the whole preparation. Carefully monitor the elution profile of correctly folded and misfolded hiss RBP at 1000 millimolar sodium chloride.Most of the misfolded hiss RBP should be released. Recover the correctly folded hollow RBP from the peak fractions at 360 millimolar sodium chloride. Following HPLC pool the fractions containing RBP in a 15 milliliter conical tube on ice.Then use the 10 kilodalton molecular weight cutoff concentrator to concentrate after the volume has been reduced by five to 10 fold. Add PBS to dilute the sample and concentrate again the next day. Use a spectrophotometer to determine the final yield and quality as shown here.Correctly folded product should have a 330 nanometer to 280 nanometer ratio. Close to one incorrectly folded protein will have a ratio less than one to produce A-O-R-B-P. Add an equal volume of heptane to the purified hollow RBP and mix gently by rotating overnight at four degrees Celsius centrifuge at 16, 000 G for 10 minutes at four degrees Celsius.After the spin, the top organic phase and the bottom aqueous phase are separated by a white layer. The white layer is denatured APO RBP. To retrieve the aqueous phase, bring the tip of a 500 microliter syringe needle down to the bottom of the tube and carefully aspirate the solution.Avoid the white material in the interface and transfer the solution to a new tube. Add heptane again and repeat the extraction process three times with a three hour rotation at four degrees Celsius for each after the last extraction, check absorption on a NanoDrop spectrophotometer to make sure the 330 nanometer peak has decreased to the background level. STR RRA six catalyzed.Retinol release and retinol loading can be monitored in real time by monitoring retinol fluorescence when retinol is bound, there is an increase in fluorescence at 460 nanometers when retinol is released. There is a decrease in fluorescence to perform This assay start by adding 200 microliters of blocker casein to each well of a black 96 well micro Fluor two plate incubate overnight at four degrees Celsius to prevent non-specific sticking of hollow RBP to the plastic. The next day, wash the coated wells of the microflora two plate once with 200 microliters of PBS.Then after aspirating the PBS cool the plate on ice. Add 100 microliters of PBS to the freshly prepared membranes from one to 5 million cells expressing T RRA six or control cells and pass the membranes through a gas type number 1710 Hamilton syringe six times to produce a uniform suspension. Next, dilute the membrane suspension to one milliliter using PBS.Add 50 microliters of the membrane suspension to each well and then place the plate back on ice.Here. Realtime monitoring of retinol fluorescence is measured using fluorescence optics of the polar star omega. Set up the instrument as described in the accompanying text with an excitation filter of 320 and the emission filter of 460 dash 10.Using this instrument perform a retinol release assay in which following a background read hollow RBP is added and readings are taken every 10 minutes for one to three hours. Then perform a retinol loading assay in which all trans retinol is added to the plate. Under dim red light, the plate is read once and then A-O-R-B-P is added.The reaction is then monitored continuously every five to 10 minutes for one to three hours after all of the measurements have been taken. The raw data will be shown in the Omega data analysis software. Transfer the raw data to Microsoft Excel.For data analysis retinol EGFP is a fluorescence resonance transfer or fret pair in which retinol serves as the donor and EGFP serves as the acceptor. S stra six catalyzed retinol transport from hollow R BP to EEG FP crbp one is monitored in real time by measuring retinol EEG FP fret prior to performing real-time monitoring of EEG FP crbp one fusion protein with six x hiss tag E GFP crbp one is produced in mammalian cells purified on nickel NTA resin and stored in PBS with protease inhibitors for a short period at four degrees Celsius or at negative 80 degrees Celsius for longer periods. Prepare a blocked microflora two plate and membranes as described in the previous section of this video and add 50 microliters of membrane suspension.As before. Set the polar star omega with the same settings as before with an additional emission filter of 510 to 10 and simultaneous dual emission fluorescence optics in this assay. EG FP crbp one to one micromolar final concentration is added to each well to start the reaction and a background reading is taken.Then one millimolar of hollow RBP is added and measurements are taken every five to 10 minutes for one to two hours after all measurements have been taken. Download the raw data as before. Retinol EGFP fret is calculated by the dynamic change in the ratio of the acceptor to donor emission peaks.The equation to calculate this ratio is shown here where 510 T 510 B, 460 T, and 460 B represent emissions at 510 nanometers after initiation of the reaction at 510 nanometers before a retinol or hollow RBP is added at 460 nanometers after initiation of the reaction added 460 nanometers before retinol or hollow RBP is added respectively. To study the catalytic activities of the RBP receptor STRA six, high quality RBP is produced and purified and then used to monitor stra six catalyzed reactions in real time. This figure shows a dramatic time dependent enhancement of retinol fluorescence in the reactions containing TA six retinol and A-O-R-B-P.There is little increase in retinol fluorescence in reactions without TA six. This experiment demonstrates stra six catalyzed retinol loading into APO R bp when stra catalyzed retinol transport from hollow R BP to EEG FP crbp one was assessed. There was a time dependent increase in retinol EEG FP fret in the reactions containing TA six.This suggests that stra six greatly accelerates the transport of retinol from hollow R BP to EEG FP crbp one. When using bacteria produced IBP, it is important to remember that high quality IVP is essential for functional acid involved IBP, and it is important to confirm the result of obtained from bacteria RBP using native RVP from serum. Once high quality RVP is available, it can be used to study the function of RBP receptor in real time using the technique I just described.These techniques are complementary to the classic, really activity based or HPRC based assays.

real-time-analyses-retinol-transport-membrane-receptor-plasma-retinol

Research

JoVE Journal

Biology

The aim of the present study was to validate the reproducibility of an in vitro BBB model involving a rat syngeneic co-culture of endothelial cells and astrocytes. The endothelial cell monolayer presented high TEER and low LY permeability. Expression of specific TJ proteins, functional responses to inflammation and functionality of transporters and receptors were assessed.

Setting-up an In Vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport

The metabolic status of human retinal pigment epithelial cells (H-RPE) reflects their health and function. Presented here is an optimized protocol for examining the real-time metabolic flux of H-RPE using high-resolution respirometry.

Real-Time Analysis of Bioenergetics in Primary Human Retinal Pigment Epithelial Cells Using High-Resolution Respirometry

Here, a normal-phase, high-performance liquid chromatography method is described to detect and quantify critical retinoids involved in the facilitation of visual function in both ocular and systemic tissue, in the context of the systemic vitamin A supply to generate the essential photosensitive rhodopsin chromophore 11-cis-retinal.

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography

Here, we describe two quantitative methods for studying the protein-ligand interactions of vitamin A membrane receptors and photoreceptor opsin with their respective physiological ligands.

Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein

Regulated endocytosis governs the cell surface expression levels of the majority of membrane proteins.  Here we utilize reducible, membrane impermeant biotinylation reagents to measure the endocytic rate of the dopamine transporter (DAT), a polytopic membrane protein.  The method facilitates a straightforward approach to measuring the endocytic rate of most plasma membrane proteins.

Measuring Plasma Membrane Protein Endocytic Rates by Reversible Biotinylation

This protocol describes a rapid technique to quantify the translocation of GLUT4 from the cytoplasm to the plasma membrane of cells by flow cytometry.

Quantitative Measurement of GLUT4 Translocation to the Plasma Membrane by Flow Cytometry

An in vitro method for preparing functional glucocorticoid receptor (GR)•hsp90 protein complexes from purified proteins and cellular lysates is described. The method utilizes immunoadsorption of recombinant GR followed by salt-stripping and protein complex reconstitution. The importance of cofactors and buffer conditions are discussed, as are potential method applications.

Biochemical Reconstitution of Steroid Receptor&#x2022;Hsp90 Protein  Complexes and Reactivation of Ligand Binding

Multiple-Target Tracing is a homemade algorithm developed for tracking individually labeled molecules within the plasma membrane of living cells. Efficiently detecting, estimating and tracing molecules over time at high-density provide a user-friendly, comprehensive tool to investigate nanoscale membrane dynamics.

Mapping Molecular Diffusion in the Plasma Membrane by Multiple-Target Tracing (MTT)

We demonstrate FRET between conjugated polymer polydiacetylene (PDA) and fluorophore attached to the surface of PDA liposomes for the sensing of biomolecules.  PDA liposomes also contained receptor molecules on their surfaces for biomolecules to be used as probes. Ligand-receptor interactions lead to changes in the FRET efficiency between the fluorophore and PDA which is the basis of the sensing mechanism.

Real-time Monitoring of Ligand-receptor Interactions with Fluorescence Resonance Energy Transfer

Microscale thermophoresis (MST) can be widely used for determination of binding affinity without purification of the target protein from cell lysates. The protocol involves overexpression of the GFP-fused protein, cell lysis in non-denaturing conditions, and detection of MST signal in the presence of varying concentrations of the ligand.

Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis

Learn to produce high-quality plasma retinol binding protein for real-time analysis of STRA6 receptor activities. This protocol enables monitoring of retinol transport mechanisms using bacterial expression and HPLC purification.

Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein

Explore More Videos